Literature DB >> 20624238

Response to heat pain stimulation in idiopathic Parkinson's disease.

R Nandhagopal1, Andre R Troiano, Edwin Mak, Michael Schulzer, Mary Catherine Bushnell, Alexander Jon Stoessl.   

Abstract

BACKGROUND: Pain is a prominent nonmotor symptom in Parkinson's disease (PD) but has not been well studied.
OBJECTIVE: The aim of this study is to assess thermal experience and emotional content, as well as side-to-side sensory differences in PD "off" and "on" dopaminergic therapy following thermal cutaneous stimulation.
DESIGN: Cross-sectional design.
SETTING: University teaching hospital.
METHODS: Twelve PD subjects experiencing motor fluctuations but no pain symptoms and 13 healthy controls participated in the study. Heat pain and emotional content were assessed using a thermode and visual analog scales in medication on and off states in PD and without medication in healthy controls.
RESULTS: There were no side to side differences in heat pain intensity or between PD medication on state and PD medication off state. Unexpectedly, PD subjects reported a higher degree of unpleasantness in response to heat pain while on medication compared with the off state.
CONCLUSIONS: These results suggest that the perception of heat pain is mediated, at least in part, by nondopaminergic systems in PD, while dopamine might modulate the affective component of pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624238     DOI: 10.1111/j.1526-4637.2010.00866.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  12 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

Review 2.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 3.  Recent advances in pain management based on nanoparticle technologies.

Authors:  Soraya Babaie; Arezou Taghvimi; Joo-Hyun Hong; Hamed Hamishehkar; Seongpil An; Ki Hyun Kim
Journal:  J Nanobiotechnology       Date:  2022-06-18       Impact factor: 9.429

Review 4.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

5.  Inhibition of NADPH oxidase within midbrain periaqueductal gray decreases pain sensitivity in Parkinson's disease via GABAergic signaling pathway.

Authors:  W Zhang; L Sun; X Yang; R Wang; H Wang
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

Review 6.  Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.

Authors:  Rory V Smith; Patrick Wilkins; Kirsty Bannister; Tatum M Cummins
Journal:  NPJ Parkinsons Dis       Date:  2021-03-17

7.  Dopamine precursor depletion influences pain affect rather than pain sensation.

Authors:  Laura Tiemann; Henrik Heitmann; Enrico Schulz; Jochen Baumkötter; Markus Ploner
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 8.  Classification and Characteristics of Pain Associated with Parkinson's Disease.

Authors:  Marcelo Rezende Young Blood; Marcelo Machado Ferro; Renato Puppi Munhoz; Hélio Afonso Ghizoni Teive; Carlos Henrique Ferreira Camargo
Journal:  Parkinsons Dis       Date:  2016-10-05

9.  Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers.

Authors:  Susanne Becker; Marta Ceko; Mytsumi Louis-Foster; Nathaniel M Elfassy; Marco Leyton; Yoram Shir; Petra Schweinhardt
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson's Disease via GABAergic Pathway.

Authors:  Xianbo Zhuang; Yanxiu Chen; Xianpeng Zhuang; Tuanzhi Chen; Tao Xing; Weifei Wang; Xiafeng Yang
Journal:  Front Neurol       Date:  2016-07-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.